EGFR and hepatocellular carcinoma: Furthermore, salinomycin-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with both CD133 and epidermal growth factor receptor (EGFR) aptamers could effectively target HCC cells simultaneously expressing EMT mediator EGFR and CD133 [107].